Quantum Private Wealth’s Krystal Biotech KRYS Stock Holding History

Quantum Private Wealth’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.27M	Sell	6,119 -1,062	-15%	-$317K	0.58%	36
2026 Q1	$1.85M	Hold	7,181	–	–	0.57%	38
2025 Q4	$1.77M	Sell	7,181 -24	-0.3%	-$5.05K	0.52%	38
2025 Q3	$1.27M	Hold	7,205	–	–	0.37%	54
2025 Q2	$990K	Hold	7,205	–	–	0.32%	56
2025 Q1	$1.3M	Hold	7,205	–	–	0.49%	40
2024 Q4	$1.13M	Hold	7,205	–	–	0.36%	54
2024 Q3	$1.31M	Hold	7,205	–	–	0.44%	46
2024 Q2	$1.32M	Hold	7,205	–	–	0.47%	43
2024 Q1	$1.28M	Hold	7,205	–	–	0.47%	46
2023 Q4	$894K	Hold	7,205	–	–	0.37%	64
2023 Q3	$836K	Hold	7,205	–	–	0.4%	53
2023 Q2	$846K	Hold	7,205	–	–	0.39%	61
2023 Q1	$577K	Hold	7,205	–	–	0.31%	78
2022 Q4	$571K	Hold	7,205	–	–	0.36%	74
2022 Q3	$502K	Buy	7,205 +1,000	+16%	+$72.2K	0.31%	85
2022 Q2	$407K	Sell	6,205 -177	-3%	-$11K	0.24%	98
2022 Q1	$424K	Sell	6,382 -442	-6%	-$27.6K	0.18%	114
2021 Q4	$477K	Buy	+6,824	New	+$397K	0.18%	116

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Quantum Private Wealth's KRYS Position: Q2 2026 in Review

Quantum Private Wealth reduced its Krystal Biotech (KRYS) stake by 15% in Q2 2026, selling an estimated $317K and leaving 6,119 shares worth $2.27M. The position accounts for 0.58% of the portfolio, ranked #36.

Quantum Private Wealth first reported a position in KRYS in Q4 2021 and has held it in 19 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Quantum Private Wealth held 6,119 shares of Krystal Biotech worth $2.27M as of Q2 2026.
Quantum Private Wealth sold 1,062 Krystal Biotech shares in Q2 2026, an estimated $317K.
Krystal Biotech made up 0.58% of Quantum Private Wealth's portfolio in Q2 2026, its #36 holding.
Quantum Private Wealth first reported a position in Krystal Biotech in Q4 2021 and has held it in 19 quarters since.
424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Quantum Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.